Global Follicle Stimulating Hormone 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062501701

Publication Date:

June 16, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Follicle Stimulating Hormone market size was valued at US$ 1386 million in 2024 and is forecast to a readjusted size of USD 1670 million by 2031 with a CAGR of 2.7% during review period.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report is a detailed and comprehensive analysis for global Follicle Stimulating Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Follicle Stimulating Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Follicle Stimulating Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Follicle Stimulating Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Follicle Stimulating Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Follicle Stimulating Hormone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Recombinant FSH
Urinary FSH
麻豆原创 segment by Application
Infertility Treatment
Assisted Reproductive Technology
Major players covered
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone, with price, sales quantity, revenue, and global market share of Follicle Stimulating Hormone from 2020 to 2025.
Chapter 3, the Follicle Stimulating Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Follicle Stimulating Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone.
Chapter 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Recombinant FSH
1.3.3 Urinary FSH
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Follicle Stimulating Hormone Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infertility Treatment
1.4.3 Assisted Reproductive Technology
1.5 Global Follicle Stimulating Hormone 麻豆原创 Size & Forecast
1.5.1 Global Follicle Stimulating Hormone Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Follicle Stimulating Hormone Sales Quantity (2020-2031)
1.5.3 Global Follicle Stimulating Hormone Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Merck Serono
2.1.1 Merck Serono Details
2.1.2 Merck Serono Major Business
2.1.3 Merck Serono Follicle Stimulating Hormone Product and Services
2.1.4 Merck Serono Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Merck Serono Recent Developments/Updates
2.2 MSD
2.2.1 MSD Details
2.2.2 MSD Major Business
2.2.3 MSD Follicle Stimulating Hormone Product and Services
2.2.4 MSD Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 MSD Recent Developments/Updates
2.3 IBSA
2.3.1 IBSA Details
2.3.2 IBSA Major Business
2.3.3 IBSA Follicle Stimulating Hormone Product and Services
2.3.4 IBSA Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 IBSA Recent Developments/Updates
2.4 Ferring
2.4.1 Ferring Details
2.4.2 Ferring Major Business
2.4.3 Ferring Follicle Stimulating Hormone Product and Services
2.4.4 Ferring Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Ferring Recent Developments/Updates
2.5 Livzon
2.5.1 Livzon Details
2.5.2 Livzon Major Business
2.5.3 Livzon Follicle Stimulating Hormone Product and Services
2.5.4 Livzon Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Livzon Recent Developments/Updates
2.6 Techwell
2.6.1 Techwell Details
2.6.2 Techwell Major Business
2.6.3 Techwell Follicle Stimulating Hormone Product and Services
2.6.4 Techwell Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Techwell Recent Developments/Updates
2.7 GenSci
2.7.1 GenSci Details
2.7.2 GenSci Major Business
2.7.3 GenSci Follicle Stimulating Hormone Product and Services
2.7.4 GenSci Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 GenSci Recent Developments/Updates
2.8 Gedeon Richter
2.8.1 Gedeon Richter Details
2.8.2 Gedeon Richter Major Business
2.8.3 Gedeon Richter Follicle Stimulating Hormone Product and Services
2.8.4 Gedeon Richter Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Gedeon Richter Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Follicle Stimulating Hormone Product and Services
2.9.4 Teva Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Teva Recent Developments/Updates
3 Competitive Environment: Follicle Stimulating Hormone by Manufacturer
3.1 Global Follicle Stimulating Hormone Sales Quantity by Manufacturer (2020-2025)
3.2 Global Follicle Stimulating Hormone Revenue by Manufacturer (2020-2025)
3.3 Global Follicle Stimulating Hormone Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Follicle Stimulating Hormone Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Follicle Stimulating Hormone Manufacturer 麻豆原创 Share in 2024
3.5 Follicle Stimulating Hormone 麻豆原创: Overall Company Footprint Analysis
3.5.1 Follicle Stimulating Hormone 麻豆原创: Region Footprint
3.5.2 Follicle Stimulating Hormone 麻豆原创: Company Product Type Footprint
3.5.3 Follicle Stimulating Hormone 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Follicle Stimulating Hormone 麻豆原创 Size by Region
4.1.1 Global Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
4.1.2 Global Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
4.1.3 Global Follicle Stimulating Hormone Average Price by Region (2020-2031)
4.2 North America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.3 Europe Follicle Stimulating Hormone Consumption Value (2020-2031)
4.4 Asia-Pacific Follicle Stimulating Hormone Consumption Value (2020-2031)
4.5 South America Follicle Stimulating Hormone Consumption Value (2020-2031)
4.6 Middle East & Africa Follicle Stimulating Hormone Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
5.2 Global Follicle Stimulating Hormone Consumption Value by Type (2020-2031)
5.3 Global Follicle Stimulating Hormone Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
6.2 Global Follicle Stimulating Hormone Consumption Value by Application (2020-2031)
6.3 Global Follicle Stimulating Hormone Average Price by Application (2020-2031)
7 North America
7.1 North America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
7.2 North America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
7.3 North America Follicle Stimulating Hormone 麻豆原创 Size by Country
7.3.1 North America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
7.3.2 North America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
8.2 Europe Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
8.3 Europe Follicle Stimulating Hormone 麻豆原创 Size by Country
8.3.1 Europe Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
8.3.2 Europe Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Follicle Stimulating Hormone 麻豆原创 Size by Region
9.3.1 Asia-Pacific Follicle Stimulating Hormone Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Follicle Stimulating Hormone Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
10.2 South America Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
10.3 South America Follicle Stimulating Hormone 麻豆原创 Size by Country
10.3.1 South America Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
10.3.2 South America Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Follicle Stimulating Hormone 麻豆原创 Size by Country
11.3.1 Middle East & Africa Follicle Stimulating Hormone Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Follicle Stimulating Hormone Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Follicle Stimulating Hormone 麻豆原创 Drivers
12.2 Follicle Stimulating Hormone 麻豆原创 Restraints
12.3 Follicle Stimulating Hormone Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Follicle Stimulating Hormone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone
13.3 Follicle Stimulating Hormone Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Follicle Stimulating Hormone Typical Distributors
14.3 Follicle Stimulating Hormone Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.